Trauma, tissue repair, and regeneration are frontier research areas in China and a team led by Professor Xiaobing Fu has become an important unit in this field in China. Over the past years, this team has played a key role in wound prevention, management, and some regulation making at the state level. The works on functions of growth factor and the action of these functions in regulating wound healing, stem cell biology, and its application for sweat gland regeneration, education, or training and prevention for chronic skin wounds are outstanding.
Trauma, repair, and regeneration are frontier areas in medical or biological research in China and the breakthrough in the theory and management methods may benefit the treatment of patients. The Key Laboratory of Wound Repair and Regeneration of People's Liberation Army (PLA) in China led by Professor Xiaobing Fu, has became an important unit in this field in China. Over the past years, this team has played a key role in wound prevention and management. They have also taken part in some regulation making work at the state level. Their works have made great contributions to the fields of trauma, tissue repair, and regeneration. The works on functions of growth factor, and the action of these functions in regulating wound healing, on stem cell biology and its application for sweat gland regeneration are outstanding.
Mechanisms Underlying the Rules of Growth Factors in Regulating Wound Healing
Dr Fu's group has extensively studied the dose-dependent action of growth factors on skin wound healing and found that the downregulation of receptors of some growth factors could delay wound healing speed and quality. They demonstrated the effectiveness of growth factors of different doses in acute burns and chronic cutaneous wounds such as the diabetic foot or venous ulcers. Their work has led to the production of genetically engineered drugs, for instance, recombinant bovine basic fibroblast growth factor (rbFGF) and recombinant human epidermal growth factor (rhEGF) in China. Clinical results in multiple centers revealed that granulation tissue formation and epidermal regeneration in acute burns is accelerated with rbFGF or rhEGF treatment, and the wound healing time is shortened by 2 to 4 days as compared with controls. In chronic cutaneous wounds, the wound healing rate is improved from 83% to 93% by such treatment. 1, 2 Long-term follow-up revealed no side effects of such treatment. These results were published in The Lancet, an internationally famous journal and were highly appreciated. The Lancet commented that now is "a time for healing" and "rbFGF decreased wound healing time, accelerated epidermal regeneration, and stimulated granulation tissue formation. 3 In 1998, the British Broadcasting Corporation (BBC) interviewed Dr Fu about the advances in engineered growth factors and their application to tissue repair and regeneration. In the BBC Health News item "Cow hormones beat burns," it was stated that "Scientists in China found that recombinant bovine basic fibroblast growth factor (rbFGF) decreased healing time and improved healing quality." 4 The headline of a story by Dr Beth Kapes, a staff correspondent of Dermatology Times, was "Skin regeneration through growth factors: Biotechnology makes advances, yet traditional approach central to healing." 5 Currently, rbFGF and rhEGF are used as essential drugs for treating trauma and burns in China, and in particular, rbFGF has been exported to Vietnam and other developing countries. 
Study of Serious Complications of Trauma and Burn and Their Prevention
To reduce the morbidity and mortality of serious trauma and massive deep burns, Dr Fu and his colleagues have characterized bacterial translocation in the gut in detail in terms of the relationship between free radical changes and internal organ injuries. They found that growth factors may help ameliorate ischemia-reperfusion injury and reduce early damage to the liver, lung, and intestine caused by serious trauma. Internal organ repair and regeneration could be accelerated with growth factor therapy. With the application of growth factors, in addition to other treatment, the mortality with multiple organ failure was reduced from 95% to 47%, as reported by some hospitals in China. 6 The results were published in Journal of Trauma, Journal of Surgical Research, and Wound Repair and Regeneration. Dr W. J. Lindblad, editor-in-chief of the latter journal, commented in an editorial that the work involved "bridging traditions": Today, many of the healthcare professions in China are practicing a form of medicine that bridges traditional and modern medicine. This bridging includes studies that clarify the basis for the success of Traditional Medicine approaches, not only to replace that approach. 7 In 2012, Dr R. Mani, editor-in-chief of the International Journal of Lower Extremity Wounds, stated in an editorial, "Will wound healing and tissue repair translate into a subspecialty with training for clinicians, nurses and others? You may wish to "Go East." 8
Discovery of Epidermal Cell Dedifferentiation and Regeneration of Sweat Gland With Stem Cells
The breakthrough in theory and skills in regenerating sweat glands is important for treating severe trauma and burns and for producing a new generation of tissue-engineered skin to treat other skin injuries and heritable skin diseases. In 2001, Dr Fu and colleagues found that epidermal cells could be dedifferentiated into their epidermal stem cells in vivo and in vitro with growth factor stimulation combined with other treatment. 6, 9 Using some patented techniques, they were successful in inducing human bone marrow mesenchymal stem cells to dedifferentiate into sweat glandlike cells with cell phenotype and functions similar to normal sweat gland cells. Part of the work was published in The Lancet in 2001. 6 When these induced sweat gland-like cells were transplanted into skin wounds in burn patients, a sweat gland-like structure was generated in the repaired skin, performing normal sweat function. To date, 35 patients with severe burns have undergone this innovative sweat gland regeneration process with satisfactory sweating results. The follow-up in some typical cases over 3 years demonstrated persistent sweat function. 10 However, the new generation of tissue-engineered skin with sweat glands is in a preliminary form and much work need to be done in the future. In the past 10 years, this team has done a lot in this field and published about 50 related articles in journals such as The Lancet, Science (supplement titled "Regenerative Medicine in China"), BioScience, and Wound Repair and Regeneration. Dr T. M. Beardsley, editor-in-chief of BioScience, recognized the this team's discovery of epidermal cell dedifferentiation and commented that "The work provides a fascinating overview of progress and discuss reversing the natural process of differentiation, whereby dividing cells become progressively less flexible in their developmental potential and more specialized to a particular task within a tissue" and "the use of dedifferentiation in future therapies seems plausible." 11 Dr P. A. Hebda, editor-in-chief of Wound Repair and Regeneration, stated that these works about the regeneration of sweat glands are a "landmark study," when the results were published with a cover photo. 12 When the new work "In vitro constitution and in vivo implantation of engineering skin constructs with sweat glands," was published in Biomaterials, the editor of New Scientist stated that "artificial skin graft promises to make sweat."
Establishing Education Program and Training Bases for Chronic Wound Care in China
Chronic cutaneous wounds represent a major health care burden in China and our studies found that the main etiological factors causing chronic skin wounds have been changed from trauma to diabetes from 1998 to 2008. However, wound care knowledge and the skill of health care professionals varies among hospitals and cities. Several years ago, the diagnosis and treatment of patients with chronic wounds were still varied and in a scattered state. Because most domestic hospitals do not have special clinical department for these patients, they are mainly sent to other departments such as general surgery, burn unit, endocrinology, and vascular surgery departments. The Chinese Tissue Repair Society (CTRS) leaded by Dr Fu and his colleagues Dr Lu and Dr Han has developed a 3-year training program in wound care in China that is sponsored by the World Diabetes Foundation (WDF) and the Coloplast Access to Healthcare (AtH) foundation. The project focuses on training physicians and nurses in wound care for patients with diabetic mellitus and other chronic skin wounds. In the past 3 years, more than 2000 health care professionals, including physicians and nurses, have been trained. Participants are from more than 200 hospitals in 23 provinces.
The International Journal of Lower Extremity Wounds 13 (2) About 1200 patients per month, on average, have benefited from this project. In total, 39 hospitals have become training bases to continue the education program in Beijing, Shanghai, and Hangzhou, and other cities. The aim of the program is to help Chinese medical professionals efficiently manage chronic wounds, thereby shortening the wound healing time, reducing the amputation rate and treatment costs, and improving quality of life. 13 This is a united and innovative team, and some young doctors play a key role in basic and clinical studies. Dr Biao Cheng, a postgraduate student 10 years ago, is now a famous professor in the field of wound repair and regeneration. He has made in-depth studies on the changes of neuropeptide and wound healing and has published more than 20 articles. Dr Sha Huang, a young scientist, works on the skin tissue engineering and its translation application in wounds. She has published her works in international journals, such as Biomaterials and others. Dr Ceiping Zhang, who graduated from the Academy of Military Medical Sciences, is studying the mechanisms of phenotype inversion of mesenchymal stem cells into sweat gland-like cells and discovered that the key factors involved in this action include epidermal growth factor, EDA (Ectodysplasin-A), and others. All these innovative works have been published in international journals, such as Wound Repair and Regeneration, and International Wound Journal, and others.
As a team leader in the field of wound repair and regeneration, Dr Fu was invited by Science to organize Chinese scientists in this field to have edit a supplement of Science titled "Regenerative Medicine in China." Science commented on the advances of regenerative medicine in China: "Researchers in China are making full use of these discoveries by manipulating stem and stem-like cells in new ways in order to help treat burn victims, diabetics, and those suffering the ravages of neurodegenerative diseases like Alzheimer's and Parkinson's . . ." 14 In 2008, the World Union of Wound Healing Societies (WUWHS) granted Dr Fu the "Lifetime Achievement Award" in Toronto, Canada, for "his contribution to improvements in wound management and patient outcomes" (cited from the awards speech of R. G. Sibbald, President of WUWHS).
The team's research has been supported in part by the National Basic Science and Development Programme (973 Programme), National High-Technique Programme (863 Programme), National Distinguished Young Scientists Programme, and the National Natural Science Foundation of China. They have obtained 8 patents and have published more than 300 scientific reports, including about 130 in international journals. As editor-in-chief, Dr Fu has published 12 books such as Regenerative Medicine: Basic Principles and Practices and Chinese Truamatology. Dr Fu has been awarded numerous international and national prizes for his achievements over the past 30 years, for example, "Lifetime Achievement Award" by the WUWHS for his contributions toward trauma treatment and tissue regeneration. He has been invited to lecture in more than 13 countries, including the United States, Germany, Japan, the United Kingdom, Italy, France, and Vietnam and has been Scientific Committee Member of some international congresses for the past 15 years. 
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